Qingdao Vland Biotech INC. (SHA:603739)
15.05
+0.08 (0.53%)
Apr 21, 2026, 3:00 PM CST
SHA:603739 Market Cap
SHA:603739 has a market cap or net worth of 3.81 billion as of April 21, 2026. Its market cap has increased by 16.40% in one year.
Market Cap
3.81B
Enterprise Value
4.18B
Revenue
1.39B
Ranking
n/a
PE Ratio
45.41
Stock Price
15.05
Market Cap Chart
Since January 16, 2019, SHA:603739's market cap has increased from 2.27B to 3.81B, an increase of 67.83%. That is a compound annual growth rate of 7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 3.81B | 6.36% |
| Dec 31, 2025 | 3.58B | 18.02% |
| Dec 31, 2024 | 3.03B | -21.22% |
| Dec 29, 2023 | 3.85B | 13.69% |
| Dec 30, 2022 | 3.39B | -27.76% |
| Dec 31, 2021 | 4.69B | 34.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 4.32B |
| Guanhao Biotech | 3.98B |
| Boji Medical Technology | 3.90B |
| Shanghai Serum Bio-Technology | 3.82B |
| Zhejiang Wecome Pharmaceutical Company | 3.79B |
| Baolingbao Biology | 3.75B |
| Shanghai Shen Lian Biomedical | 3.69B |
| Zhejiang Shouxiangu Pharmaceutical | 3.67B |